Meiji Yasuda Asset Management CO Ltd. Biomarin Pharmaceutical Inc Transaction History

Meiji Yasuda Asset Management CO Ltd.

$2.56 Billion
Q4 2024

A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 12,555 shares of BMRN stock, worth $895,422. This represents 0.03% of its overall portfolio holdings.

Number of Shares

12,555

Previous 12,589 0.27%

Holding current value

$895,422

Previous $884,000 6.67%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$61.93 - $70.49 $2,105 - $2,396	-34 Reduced 0.27%	12,555 $825,000
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $3,312 - $4,504	-48 Reduced 0.38%	12,589 $884,000
Q2 2024 Aug 12, 2024	BUY	$74.43 - $92.22 $426,558 - $528,512	5,731 Added 82.99%	12,637 $1.04 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $715,905 - $845,658	-8,542 Reduced 55.3%	6,906 $603,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $23,628 - $30,538	310 Added 2.05%	15,448 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $639,726 - $710,489	7,520 Added 98.71%	15,138 $1.34 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $7,107 - $8,224	-82 Reduced 1.06%	7,618 $660,000
Q1 2023 May 09, 2023	SELL	$87.74 - $117.27 $676,563 - $904,268	-7,711 Reduced 50.04%	7,700 $749,000
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $1,618 - $2,172	-20 Reduced 0.13%	15,411 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $131,456 - $155,104	1,600 Added 11.57%	15,431 $1.31 Million
Q2 2022 Aug 16, 2022	BUY	$71.48 - $86.85 $7,148 - $8,685	100 Added 0.73%	13,831 $1.15 Million
Q1 2022 May 17, 2022	SELL	$74.28 - $92.69 $17,827 - $22,245	-240 Reduced 1.72%	13,731 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $344,256 - $439,056	4,800 Added 52.34%	13,971 $1.23 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $12,836 - $14,414	-170 Reduced 1.82%	9,171 $765,000
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $69,498 - $84,341	930 Added 11.06%	9,341 $705,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $301,331 - $374,330	4,150 Added 97.39%	8,411 $738,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $95,587 - $174,269	-1,330 Reduced 23.79%	4,261 $324,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $444,764 - $694,514	5,591 New	5,591 $690,000
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $170,645 - $231,568	-2,391 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $153,669 - $206,510	2,391 New	2,391 $202,000
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $161,153 - $203,498	-2,391 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $192,116 - $224,514	2,391 New	2,391 $205,000
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $168,374 - $222,853	-2,101 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $197,325 - $222,117	2,101 New	2,101 $204,000

Others Institutions Holding BMRN

# of Institutions

628

Shares Held

183M

Call Options Held

Put Options Held

1.67M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.

Account

Meiji Yasuda Asset Management CO Ltd. Biomarin Pharmaceutical Inc Transaction History